Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
True there, still adding SCON calls
looks like i should have held those cldx common and calls for an even bigger gain.. but alas
sold CLDX 16.50 from 14.50 sold 15$ weekly calls 1.60 from .55
all friday last 20 minutes
@RTNRTN
sold CLDX 16.50 from 14.50 sold 15$ weekly calls 1.60 from .55
all friday last 20 minutes
sold CLDX 16.50 from 14.50 sold 15$ weekly calls 1.60 from .55
all friday last 20 minutes
ROTH Capital reiterated Celldex Therapeutics (CLDX) $43 coverage with Buy and target $43
CLDX great survival data last friday after hours, unexpectedly good surprise
ROTH Capital reiterated Celldex Therapeutics (CLDX) $43 coverage with Buy and target $43
Next question would be: bob .. where are you at than
CLDX webcast at 5pm to discuss results.. very positive imo.
CLDX confusing headlines.. now the pop.LONG common shares now and next week 15$ calls
RT @RTNRTN: RT : Bloomberg headline of $CLDX results in avastin refractory patients failing is causing confusion - even though the results are positive
CLDX data out
will take AMAT puts next week due to big open interest on its calls
AKAM up on BABA rumours
SCON next week negotiations wih potential big client per todays cc .. worth listening to
SCON next week negotiations wih potential big client per todays cc .. worth listening to
FUEL pop
ye i see
YY should be up tomorrow, maybe AH and AM games, but numbers were good
Yes it can, but valuation was low, earnings good and outlook good, actual buybacks are being done, more approved and high short ratio...and
biased to 120+ 125+ tomorrow
hmm.. what happened there-- might be problem with my mouse
FOSL 1 billion buyback approval now on earnings
FOSL Q3 "invested $133.8 million to repurchase 1.3 million shares of its common stock at an average price of $101"
FOSL Q3 "invested $133.8 million to repurchase 1.3 million shares of its common stock at an average price of $101"
FOSL Q3 "invested $133.8 million to repurchase 1.3 million shares of its common stock at an average price of $101"
so actually rebuying it as well, not just announcing it
FOSL Q3 "invested $133.8 million to repurchase 1.3 million shares of its common stock at an average price of $101"
FOSL also 1 billion buyback and 12.5% or so shorts
FOSL Fossil, Inc. Reports Q3 EPS of $1.96 vs $1.82 Est; Revenue of $894.50M vs $878.80M Est Bullish
YY FOSL earnings
ZTS Ackaman takes 2bln stake
USO green, NUGT nice , JPM puts seem to work
NUGT hod
NUGT 13c at .50
BBSI -- $0 target Negative fraud piece -- Copperfield research updating its call on BBSI with a new price target of 0 to 8.76 from $29 https://www.scribd.com/doc/246261615/Barrett-Business-Services-BBSI-Throwing-Good-Money-at-Bad
USO green